Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R).

ABSTRACT:

SUBMITTER: De Carolis L 

PROVIDER: S-EPMC12616395 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature